Stryker | SYK - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Abbott USD 52.06B 69M 2026-03
AtriCure USD 516.43M 24.74M 2026-06
Baxter International USD 6.21B 163M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Boston Scientific USD 24.93B 934M 2026-06
CONMED USD 1.04B 23.72M 2026-06
Cooper Companies USD 8.36B 124.7M 2025-12
Danaher USD 52.58B 368M 2026-06
Dexcom USD 2.62B 335.5M 2026-06
Edwards Lifesciences USD 10.62B 290.5M 2026-06
Globus Medical USD 4.77B 36.29M 2026-06
Haemonetics USD 837.1M 40.78M 2026-06
Insulet USD 1.42B 119.6M 2026-06
Integra LifeSciences USD 1.04B 971K 2026-06
Intuitive Surgical USD 18.17B 693.9M 2026-06
J&J USD 84.97B 3.78B 2026-06
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.68B 53.08M 2026-06
Olympus JPY 747.9B 64.14B 2026-06
Smith & Nephew USD 5.18B 356M 2026-06
Steris USD 7.21B 23.1M 2026-06
Stryker USD 22.98B 559M 2026-03
Tandem Diabetes Care USD 130.39M 2.02M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
Terumo JPY 1.66T 77.51B 2026-06
Zimmer Biomet Holdings USD 12.63B 49.1M 2026-06